TEP Diabetes
Clinical proof of concept
A working prototype demonstrating TEP’s early-warning capability on glucose data. Validated on continuous glucose monitoring (CGM) data from 109 Type 2 diabetes patients and designed to identify risk trajectories while values still appear within normal ranges. In practice, it is an early-warning layer for medicine — reading the history of a signal to flag risk before the numbers move, giving clinicians time to act.